JFG
TSHA icon

Jefferies Financial Group’s Taysha Gene Therapies TSHA Stock Holding History

Jefferies Financial Group’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Buy
479,000
+454,000
+1,816% +$2.11M 0.01% 618
2025
Q4 		$138K Sell
25,000
-2,131,642
-99% -$10.4M ﹤0.01% 1668
2025
Q3 		$7.05M Sell
2,156,642
-8,157,091
-79% -$23.1M 0.03% 283
2025
Q2 		$23.8M Buy
10,313,733
+10,068,479
+4,105% +$21.9M 0.2% 94
2025
Q1 		$341K Buy
+245,254
New +$410K ﹤0.01% 1189
2024
Q4 		– Sell
-73,857
Closed -$148K – 1861
2024
Q3 		$148K Sell
73,857
-183,837
-71% -$403K ﹤0.01% 1253
2024
Q2 		$577K Buy
257,694
+209,594
+436% +$610K 0.01% 921
2024
Q1 		$138K Buy
+48,100
New +$100K ﹤0.01% 1395

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM